Fundraising FoxKempharm
NASDAQ: ZVRACoralville, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into Kempharm
Sign up to see every warm intro you have to Kempharm
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kempharm team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Kempharm was founded in 2014 by Travis C. Mickle and Christal M.M. Mickle.
TC
Travis C. MickleCo-founder
CM
Christal M.M. MickleCo-founder
GK
Gordon K. JohnsonExecutive
TM
Tracy M. WoodyExecutive
SG
Sven GuentherExecutive
NF
Neil F. McFarlanePresident, Chief Executive Officer and Director
AQ
Adrian QuartelChief Medical Officer
JS
Joshua SchaferChief Commercial Officer
RW
Rahsaan W. ThompsonChief Legal Officer, Secretary and Compliance Officer
JR
Justin RenzChief Financial Officer
Board
MR
Matthew R. PloosterBoard director
JS
Jonathan S. LeffBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$194.2M disclosed across 7 of 8 rounds · 1900–2021
▶$39.1MraisedJun 2021 · 12 investors · PharmaceuticalsRule 506(b)
▶$39.1MraisedJun 2021 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- R. LaDuane CliftonExecutive Officer
- Timothy J. SangiovanniExecutive Officer
- Travis C. MickleExecutive Officer, Director, Promoter
- Joseph B. SaluriDirector
- Sven GuentherExecutive Officer
- David S. TierneyDirector
- Matthew R. PloosterDirector
- Richard W. PascoeDirector
- Offering amount
- $39.1M
- Amount sold
- $39.1M
- Sales commissions
- $2.3M
- Placement agents
- Roth Capital Partners, LLC
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$44MraisedFeb 2021 · 15 investors · PharmaceuticalsRule 506(b)
▶$44MraisedFeb 2021 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sven GuentherExecutive Officer
- Timothy J. SangiovanniExecutive Officer
- Richard W. PascoeDirector
- Matthew R. PloosterDirector
- Joseph B. SaluriDirector
- David S. TierneyDirector
- Travis C. MickleExecutive Officer, Director, Promoter
- R. LaDuane CliftonExecutive Officer
- Offering amount
- $44M
- Amount sold
- $44M
- Sales commissions
- $2.6M
- Placement agents
- Roth Capital Partners, LLC
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$31.5MraisedJan 2021 · 4 investors · PharmaceuticalsRule 506(b)
▶$31.5MraisedJan 2021 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph B. SaluriDirector
- David S. TierneyDirector
- Travis C. MickleExecutive Officer, Director, Promoter
- Matthew R. PloosterDirector
- Sven GuentherExecutive Officer
- Timothy J. SangiovanniExecutive Officer
- Richard W. PascoeDirector
- R. LaDuane CliftonExecutive Officer
- Offering amount
- $31.5M
- Amount sold
- $31.5M
- Finders' fees
- $2M
- Placement agents
- Cowen & Company, LLC
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedJan 2020 · 1 investors · PharmaceuticalsRule 506(b)
▶$3MraisedJan 2020 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- R. LaDuane CliftonExecutive Officer
- Gordon K. JohnsonExecutive Officer
- Sven GuentherExecutive Officer
- David S. TierneyDirector
- Richard W. PascoeDirector
- Matthew R. PloosterDirector
- Joseph B. SaluriDirector
- Travis C. MickleExecutive Officer, Director, Promoter
- Timothy J. SangiovanniExecutive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$71.4MraisedDec 2019 · 3 investors · PharmaceuticalsRule 506(b)
▶$71.4MraisedDec 2019 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Travis C. MickleExecutive Officer, Director, Promoter
- R. LaDuane CliftonExecutive Officer
- Gordon K. JohnsonExecutive Officer
- Sven GuentherExecutive Officer
- David S. TierneyDirector
- Richard W. PascoeDirector
- Matthew R. PloosterDirector
- Joseph B. SaluriDirector
- Timothy J. SangiovanniExecutive Officer
- Offering amount
- $71.4M
- Amount sold
- $71.4M
- Sales commissions
- $530K
- Placement agents
- Cowen & Company, LLC
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedNov 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.1MraisedNov 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard W. PascoeDirector
- Joseph B. SaluriDirector
- R. LaDuane CliftonExecutive Officer
- Sven GuentherExecutive Officer
- Travis C. MickleExecutive Officer, Director, Promoter
- David S. TierneyDirector
- Matthew R. PloosterDirector
- Danny L. ThompsonDirector
- Gordon K. JohnsonExecutive Officer
- Timothy J. SangiovanniExecutive Officer
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4MraisedMar 2015 · 1 investors · PharmaceuticalsRule 506(b)
▶$4MraisedMar 2015 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gordon K. JohnsonExecutive Officer
- David S. TierneyDirector
- Matthew R. PloosterDirector
- Travis C. MickleExecutive Officer, Director, Promoter
- Tracy M. WoodyExecutive Officer
- Richard W. PascoeDirector
- Christal M.M. MickleExecutive Officer, Director
- Danny L. ThompsonDirector
- Joseph B. SaluriDirector
- Sven GuentherExecutive Officer, Director
- Jonathan S. LeffDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Kempharm?
- Kempharm was founded by Travis C. Mickle, Christal M.M. Mickle in 2014.
- Who are Kempharm's investors?
- Kempharm's investors include ALS Investment Fund.
- How much funding has Kempharm raised?
- Kempharm has disclosed $194.2M raised across 7 of its 8 known rounds.
- Where is Kempharm headquartered?
- Kempharm is headquartered in Coralville, US.